Drug
Pegfilgrastim Bmez
Pegfilgrastim Bmez: highest development phase Approved, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZIEXTENZO | Approved |
Latest
No recent events.
Follow Pegfilgrastim Bmez on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.